Comments
Consumer healthcare products giant Glaxosmithkline Consumer Healthcare Ltd has done a HUL, registering a near 16 per cent increase in sales in the quarter ended March 31, 2013.
It is the first quarter for the current year for the company as it follows a Jan-Dec fiscal.
Net profit during the period has gone up about 20 per cent compared to the corresponding quarter in the previous financial year.
According to the standalone unaudited results for the quarter ended March 31, 2013, the total income from operations (net) was Rs 975.38 crore against Rs 836.41 crore during the same period in the previous financial year.
Net profit for the quarter was Rs 156.41 crore against Rs 131.97 crore in the corresponding quarter during last year. EPS (share face value Rs 10) for the quarter was also sharply up at Rs 37.19 (Rs 31.38).
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.